XML 128 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Leases
12 Months Ended
Dec. 31, 2019
Leases [Abstract]  
Leases Leases
The Company conducts its operations using facilities leased under operating lease agreements that expire at various dates. The Company finances its use of certain motor vehicles and other equipment under various lease arrangements provided by financial institutions.
The Company has performed an evaluation of its contracts with suppliers in accordance with Topic 842 and has determined that, except for leases for office facilities, motor vehicles and other equipment as described above, none of the Company’s contracts contain a lease.
In assessment of the lease term, the Company considers the extension option as part of its lease term for those lease arrangements where the Company is reasonably certain of availing the extension option.
The lease agreements do not contain any covenant to impose any restrictions except for market-standard practice for similar lease arrangements.




Supplemental balance sheet information
 
 
As of
 
 
December 31, 2019
Operating Lease
 
 
Operating lease right-of-use assets
 
$
86,396

 
 
 
Operating lease liabilities - Current
 
$
24,148

Operating lease liabilities - Non-current
 
74,709

    Total operating lease liabilities
 
$
98,857

 
 
 
Finance Lease
 
 
Property and equipment, gross
 
$
1,757

Accumulated depreciation
 
(1,120
)
    Property and equipment, net
 
$
637

 
 
 
Finance lease liabilities - Current
 
$
253

Finance lease liabilities - Non-current
 
430

   Total finance lease liabilities
 
$
683


During the year ended December 31, 2019, the Company performed an impairment test of its long-lived assets related to its Health Integrated business. Based on the results, the operating lease right-of-use assets carrying value exceeded its fair value. The primary factor contributing to a reduction in the fair value is the wind down of the Health Integrated business, due to an anticipated reduction to the Company's estimated future cash flows. As a result of this analysis, the Company recognized an impairment charge of $1,449 during year ended December 31, 2019, to write down the carrying value of operating lease right-of-use assets to its fair value. This impairment charge was recorded in the consolidated statements of income under "Impairment and restructuring charges". Refer to Note 24 to the consolidated financial statements for further details.
The components of lease cost, which are included in the Company's consolidated statements of income, are as follows:
Lease cost

 
Year ended December 31, 2019
Finance lease:
 
 
     Amortization of right-of-use assets
 
$
255

     Interest on lease liabilities
 
93

Operating lease(a)
 
27,335

Sublease income
 
(146
)
Total lease cost
 
$
27,537


Operating lease cost for leases classified as such under Topic 840 for the years ended December 31, 2018, and 2017 was $25,573 and $24,015, respectively.
(a) Includes short-term leases, which are immaterial.
Supplemental cash flow and other information related to leases are as follows:
 
 
Year ended
December 31, 2019
Cash payments for amounts included in the measurement of lease liabilities :
 
 
Operating cash outflows for operating leases
 
$
24,813

Operating cash outflows for finance leases
 
$
93

Financing cash outflows for finance leases
 
$
336

Right-of-use assets obtained in exchange for new operating lease liabilities
 
$
36,473

Right-of-use assets obtained in exchange for new finance lease liabilities
 
$
506

Weighted-average remaining lease term
 
 
Finance lease
 
2.3 years

Operating lease
 
6.0 years

Weighted-average discount rate
 
 
Finance lease
 
9.9
%
Operating lease
 
7.6
%

The Company determines the incremental borrowing rate by adjusting the benchmark reference rates, applicable to the respective geographies where the leases were entered, with appropriate financing spreads and lease specific adjustments for the effects of collateral.
As of December 31, 2019, the Company has entered into an operating lease for a facility that has not yet commenced with lease liability of approximately $11,900. This operating lease will commence in January 2020 and has a lease term of 15 years.
Maturities of lease liabilities as of December 31, 2019 are as follows:
 
 
Operating Leases
 
Finance Leases
2020
 
$
26,932

 
$
325

2021
 
23,783

 
251

2022
 
21,526

 
157

2023
 
19,381

 
86

2024
 
14,865

 
22

2025 and thereafter
 
23,983

 

Total lease payments
 
$
130,470

 
$
841

Less: Imputed interest
 
31,613

 
158

Present value of lease liabilities
 
$
98,857

 
$
683


Maturities of minimum lease payments as of December 31, 2018 are as follows:
During the next twelve months ending December 31,
Operating Leases
 
Capital Leases
2019
$
23,431

 
$
283

2020
20,039

 
163

2021
16,924

 
120

2022
14,804

 
58

2023
12,859

 
49

2024
11,114

 

2025 and thereafter
15,000

 

Total minimum lease payment
$
114,171

 
$
673

Less: imputed interest
NA

 
135

Present value of minimum lease payments
NA

 
538

Less: current portion
NA

 
223

Long term capital lease obligation
NA

 
$
315


Leases Leases
The Company conducts its operations using facilities leased under operating lease agreements that expire at various dates. The Company finances its use of certain motor vehicles and other equipment under various lease arrangements provided by financial institutions.
The Company has performed an evaluation of its contracts with suppliers in accordance with Topic 842 and has determined that, except for leases for office facilities, motor vehicles and other equipment as described above, none of the Company’s contracts contain a lease.
In assessment of the lease term, the Company considers the extension option as part of its lease term for those lease arrangements where the Company is reasonably certain of availing the extension option.
The lease agreements do not contain any covenant to impose any restrictions except for market-standard practice for similar lease arrangements.




Supplemental balance sheet information
 
 
As of
 
 
December 31, 2019
Operating Lease
 
 
Operating lease right-of-use assets
 
$
86,396

 
 
 
Operating lease liabilities - Current
 
$
24,148

Operating lease liabilities - Non-current
 
74,709

    Total operating lease liabilities
 
$
98,857

 
 
 
Finance Lease
 
 
Property and equipment, gross
 
$
1,757

Accumulated depreciation
 
(1,120
)
    Property and equipment, net
 
$
637

 
 
 
Finance lease liabilities - Current
 
$
253

Finance lease liabilities - Non-current
 
430

   Total finance lease liabilities
 
$
683


During the year ended December 31, 2019, the Company performed an impairment test of its long-lived assets related to its Health Integrated business. Based on the results, the operating lease right-of-use assets carrying value exceeded its fair value. The primary factor contributing to a reduction in the fair value is the wind down of the Health Integrated business, due to an anticipated reduction to the Company's estimated future cash flows. As a result of this analysis, the Company recognized an impairment charge of $1,449 during year ended December 31, 2019, to write down the carrying value of operating lease right-of-use assets to its fair value. This impairment charge was recorded in the consolidated statements of income under "Impairment and restructuring charges". Refer to Note 24 to the consolidated financial statements for further details.
The components of lease cost, which are included in the Company's consolidated statements of income, are as follows:
Lease cost

 
Year ended December 31, 2019
Finance lease:
 
 
     Amortization of right-of-use assets
 
$
255

     Interest on lease liabilities
 
93

Operating lease(a)
 
27,335

Sublease income
 
(146
)
Total lease cost
 
$
27,537


Operating lease cost for leases classified as such under Topic 840 for the years ended December 31, 2018, and 2017 was $25,573 and $24,015, respectively.
(a) Includes short-term leases, which are immaterial.
Supplemental cash flow and other information related to leases are as follows:
 
 
Year ended
December 31, 2019
Cash payments for amounts included in the measurement of lease liabilities :
 
 
Operating cash outflows for operating leases
 
$
24,813

Operating cash outflows for finance leases
 
$
93

Financing cash outflows for finance leases
 
$
336

Right-of-use assets obtained in exchange for new operating lease liabilities
 
$
36,473

Right-of-use assets obtained in exchange for new finance lease liabilities
 
$
506

Weighted-average remaining lease term
 
 
Finance lease
 
2.3 years

Operating lease
 
6.0 years

Weighted-average discount rate
 
 
Finance lease
 
9.9
%
Operating lease
 
7.6
%

The Company determines the incremental borrowing rate by adjusting the benchmark reference rates, applicable to the respective geographies where the leases were entered, with appropriate financing spreads and lease specific adjustments for the effects of collateral.
As of December 31, 2019, the Company has entered into an operating lease for a facility that has not yet commenced with lease liability of approximately $11,900. This operating lease will commence in January 2020 and has a lease term of 15 years.
Maturities of lease liabilities as of December 31, 2019 are as follows:
 
 
Operating Leases
 
Finance Leases
2020
 
$
26,932

 
$
325

2021
 
23,783

 
251

2022
 
21,526

 
157

2023
 
19,381

 
86

2024
 
14,865

 
22

2025 and thereafter
 
23,983

 

Total lease payments
 
$
130,470

 
$
841

Less: Imputed interest
 
31,613

 
158

Present value of lease liabilities
 
$
98,857

 
$
683


Maturities of minimum lease payments as of December 31, 2018 are as follows:
During the next twelve months ending December 31,
Operating Leases
 
Capital Leases
2019
$
23,431

 
$
283

2020
20,039

 
163

2021
16,924

 
120

2022
14,804

 
58

2023
12,859

 
49

2024
11,114

 

2025 and thereafter
15,000

 

Total minimum lease payment
$
114,171

 
$
673

Less: imputed interest
NA

 
135

Present value of minimum lease payments
NA

 
538

Less: current portion
NA

 
223

Long term capital lease obligation
NA

 
$
315